[go: up one dir, main page]

IT8119360A0 - 17alfa-acilossi-5beta-corticoidi e 17alfa-acilossi-5alfa-corticoidi. - Google Patents

17alfa-acilossi-5beta-corticoidi e 17alfa-acilossi-5alfa-corticoidi.

Info

Publication number
IT8119360A0
IT8119360A0 IT8119360A IT1936081A IT8119360A0 IT 8119360 A0 IT8119360 A0 IT 8119360A0 IT 8119360 A IT8119360 A IT 8119360A IT 1936081 A IT1936081 A IT 1936081A IT 8119360 A0 IT8119360 A0 IT 8119360A0
Authority
IT
Italy
Prior art keywords
17alfa
corticoids
acyloxy
5alfa
5beta
Prior art date
Application number
IT8119360A
Other languages
English (en)
Other versions
IT1193576B (it
Inventor
Donald Emory Ayer
Carl Alvin Schlagel
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of IT8119360A0 publication Critical patent/IT8119360A0/it
Application granted granted Critical
Publication of IT1193576B publication Critical patent/IT1193576B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT19360/81A 1980-01-31 1981-01-27 17alfa-acilossi-5beta-corticoidi e 17alfa-acilossi-5alfa-corticoidi IT1193576B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/117,401 US4318853A (en) 1980-01-31 1980-01-31 9β,11β-Epoxy-5β-corticoids

Publications (2)

Publication Number Publication Date
IT8119360A0 true IT8119360A0 (it) 1981-01-27
IT1193576B IT1193576B (it) 1988-07-08

Family

ID=22372732

Family Applications (1)

Application Number Title Priority Date Filing Date
IT19360/81A IT1193576B (it) 1980-01-31 1981-01-27 17alfa-acilossi-5beta-corticoidi e 17alfa-acilossi-5alfa-corticoidi

Country Status (18)

Country Link
US (1) US4318853A (it)
JP (1) JPS56122398A (it)
KR (1) KR850001208B1 (it)
AU (1) AU538883B2 (it)
BE (1) BE887323A (it)
CA (1) CA1155108A (it)
CH (1) CH644614A5 (it)
DE (1) DE3102397A1 (it)
DK (1) DK39281A (it)
ES (1) ES8300342A1 (it)
FR (1) FR2475048A1 (it)
GB (1) GB2070016B (it)
GR (1) GR73511B (it)
IT (1) IT1193576B (it)
NL (1) NL8100467A (it)
PH (2) PH16525A (it)
SE (1) SE8100563L (it)
ZA (1) ZA8118B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3243482A1 (de) * 1982-11-22 1984-05-24 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung
ES2041245T3 (es) * 1985-10-23 1993-11-16 The Upjohn Company Esteroides angioestaticos.
NL8900507A (nl) * 1989-03-02 1990-10-01 Philips Nv Versterkerschakeling met verzadigingsdetectie.
CA2139549A1 (en) * 1994-01-28 1995-07-29 Kazumi Ogata Corticoid derivatives and pharmaceutical and cosmetic compositions
GB2302807A (en) * 1995-07-04 1997-02-05 Surtech Int Ltd Method and composition for treating atopic eczema
DE19737348C2 (de) * 1997-08-27 2002-07-25 Dan-Gabriel Vulpescu Neue Clindamycin und Clotrimazol enthaltende pharmazeutische Zusammensetzung
ITMI20071616A1 (it) 2007-08-03 2009-02-04 Cosmo Spa Processo enzimatico per l'ottenimento di 17-alfa monoesteri del cortexolone e/o suoi 9,11-deidroderivati.
EP3656385A1 (en) 2008-05-28 2020-05-27 ReveraGen BioPharma, Inc. Non-hormonal steroid modulators of nf-kb for treatment of disease
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
CN102225959B (zh) * 2011-04-29 2012-11-07 中国科学院上海有机化学研究所 一种16β-甲基-17α-羟基孕甾-3,20-二酮化合物及其合成方法
WO2017004205A1 (en) 2015-06-29 2017-01-05 Reveragen Biopharma, Inc. NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2831874A (en) * 1954-04-20 1958-04-22 Gnrd Patent Holdings Ltd Improvements in the preparation of 17:21-diacyloxy-2:4-dibromo-3:11:20-triketoallopregnanes
US2854465A (en) * 1955-02-18 1958-09-30 Ciba Pharm Prod Inc Process for the manufacture of halogen-pregnanes and dehalogenation products thereof
DE1195748B (de) * 1961-06-24 1965-07-01 Vismara Francesco Spa Verfahren zur Herstellung von 1'-substituierten 17alpha, 21-(1'-Alkoxy)-methylendioxysterioden
US3681410A (en) * 1970-08-07 1972-08-01 Syntex Corp Process for preparing 17{60 -hydroxy-20-keto and 17{60 ,21-dihydroxy-20-keto pregnanes and derivatives and intermediates thereof

Also Published As

Publication number Publication date
FR2475048A1 (fr) 1981-08-07
GB2070016B (en) 1983-09-14
US4318853A (en) 1982-03-09
ES498938A0 (es) 1982-11-01
CH644614A5 (de) 1984-08-15
KR850001208B1 (ko) 1985-08-20
IT1193576B (it) 1988-07-08
DK39281A (da) 1981-08-01
DE3102397A1 (de) 1981-12-24
GB2070016A (en) 1981-09-03
JPS56122398A (en) 1981-09-25
GR73511B (it) 1984-03-07
ES8300342A1 (es) 1982-11-01
ZA8118B (en) 1982-01-27
BE887323A (fr) 1981-07-30
SE8100563L (sv) 1981-08-01
FR2475048B1 (it) 1984-11-16
NL8100467A (nl) 1981-09-01
AU6651381A (en) 1981-08-06
CA1155108A (en) 1983-10-11
PH19579A (en) 1986-05-26
KR830005263A (ko) 1983-08-03
PH16525A (en) 1983-11-10
AU538883B2 (en) 1984-08-30

Similar Documents

Publication Publication Date Title
MX9203117A (es) Benzotiofenos antiestrogenicos y antiandrogenicos.
FI77044B (fi) Sidokedjade l-aspartyl-d-aminosyra- dipeptidsyror.
FI811552A7 (fi) Moniejektori.
ATE15191T1 (de) Antihypertensiva.
IT8120771V0 (it) Convogliatore.
ES267107Y (es) Segueta.
FI814005A7 (fi) Fenoksialkoksisilaaneja.
IT8119047A0 (it) Cicloesen-derivati.
IT8119360A0 (it) 17alfa-acilossi-5beta-corticoidi e 17alfa-acilossi-5alfa-corticoidi.
IT8119473A0 (it) 3-amidino-ansamicine.
FI73924B (fi) Loesbladspaerm.
IT8120864V0 (it) Stereogiocattolo logico.
BE888474A (fr) 1omega-hydroxy-2 beta-fluorocholecalciferol.
NO803713L (no) Bensement og anvendelse derav.
IT8125692A0 (it) 5alfa-androstan-17beta-carbossilati e 5beta-androstan-17beta-carbossilati .
FI73532B (fi) Dubbelfrekvent stoeldbekaempningssystem.
FI812780A7 (fi) Bis-tetratsolimetyylitiolit.
IT8026945A0 (it) Chetoidrossiimminocefalosporine.
FI812232A7 (fi) Pyridinyyliaminofenolit.
IT8026909A0 (it) Racla.
IT8023769A0 (it) Piretroidi.
IT8022166A0 (it) N.mercaptoacil-dipeptidi ederivati.
IT8024010A0 (it) Immino-alchile e ammino-nitrile cian-guanidine.
ATE9650T1 (de) Makrolide.
ATE17118T1 (de) 2-methylseleno-benzamide.